TRASTUZUMAB DERUXTECAN + Palacaparib

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

TRASTUZUMAB DERUXTECAN + Palacaparib
Treatment and conditionWhere it standsTrials
TRASTUZUMAB DERUXTECAN + Palacaparib for astrocytomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
TRASTUZUMAB DERUXTECAN + Palacaparib for fallopian tube neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
TRASTUZUMAB DERUXTECAN + Palacaparib for prostatic neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1